TARGET
saveCDK4/6
Cyclin-dependent kinases 4 and 6; HR+ breast cancer target.
also known as: cdk4, cdk6, cyclin-dependent kinase 4/6
drugs
0
catalysts
0
news
50
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- Iambic goes public with $150M IPO to accelerate clinical development of oncology pipelinefiercebiotech · 4d ago
- Iambic, an AI drug discovery specialist, banks $150M in an IPObiopharma dive · 4d ago
- AI biotech Iambic aims for $135M IPO to push cancer drugs through clinicfiercebiotech · 10d ago
- Iambic maintains momentum from string of Big Pharma partnerships by aiming for IPOfiercebiotech · 27d ago
- AstraZeneca’s newly approved cancer pill fails late-stage study, blocking path to bigger marketbiospace · 1mo ago
- AstraZeneca’s SERD pill overcomes adcomm defeat to win FDA nod in breast cancerbiospace · 1mo ago
- FDA approves AstraZeneca’s Etcamah, opening ctDNA-guided treatment paradigm in breast cancerfiercebiotech · 1mo ago
- Guardant wins FDA nod for diagnostic guiding use of AstraZeneca’s Etcamahfiercebiotech · 1mo ago
Data sources
last refreshed 36m ago
Found something off?
comments(0)
5-min edit window · permanent after that